CSL - Current Assets

Stock Price
130.00
Daily Change
1.00 0.78%
Monthly
-7.79%
Yearly
-46.78%
Q2 Forecast
127.56

CSL reported $11.85B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 37.91M 15.92M Dec/2025
Arca Biopharma USD 343.86M 11.31M Dec/2025
aTyr Pharma USD 245.8M 152.79M Dec/2025
Bio Path USD 663K 17K Sep/2025
Brainstorm Cell Therapeutics USD 307K 201K Dec/2025
Cara Therapeutics USD 38.44M 4.69M Sep/2025
CSL USD 11.85B 1000K Dec/2025
Curis USD 6.92M 7.5M Dec/2025
Esperion Therapeutics USD 462.57M 102.11M Dec/2025
Immunic USD 39.27M 20.57M Sep/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
TherapeuticsMD USD 11.82M 303K Jun/2024